SEN Virus Infection and the Risk of Hepatocellular Carcinoma: A Case-Control Study

American Journal of Gastroenterology

Volumn 98, Issue 11, 2003, Pages 2500-2504

  Tangkijvanich, Pisit ^b   Theamboonlers, Apiradee ^b   Sriponthong, Maturapod ^b   Kullavanijaya, Pinit ^b   Poovorawan, Yong ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIGEN; RNA; VIRUS DNA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD SAMPLING; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GEOGRAPHY; HEPATITIS B; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PATIENT SELECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEN VIRUS; SEX DIFFERENCE; STATISTICAL ANALYSIS; VIRUS CARCINOGENESIS; VIRUS DETECTION;

EID: 0344496157     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07689.x     Document Type: Article

References (24)

1. Sallie R, Di Bisceglie AM. Viral hepatitis and hepatocellular carcinoma. Gastroenterol Clin North Am 1994;23:567-79.
2. Vatanasapt V, Martin N, Sriplung H, et al. Cancer incidence in Thailand, 1988-1991. Cancer Epidemiol Biomarkers Prev 1995;4:475-83.
3. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999;353:1253-7.
4. Monto A, Wright TL. The epidemiology and prevention of hepatocellular carcinoma. Semin Oncol 2001;28:441-9.
5. Primi D, Fiordalisi G, Mattioli S, et al. Identication of SENV genotypes. International publication: WO 00/28039 2000 (International application published under the patent cooperation treaty).
6. Tanaka Y, Primi D, Wang RY, et al. Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. J Infect Dis 2001;183:359-67.
7. Umemura T, Yeo AE, Sottini A, et al. SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology 2001;33:1303-11.
8. Shibata M, Wang RY, Yoshiba M, et al. The presence of a newly identified infectious agent (SEN virus) in patients with liver diseases and in blood donors in Japan. J Infect Dis 2001;184:400-4.
9. Kao JH, Chen W, Chen PJ, et al. Prevalence and implication of a newly identified infectious agent (SEN virus) in Taiwan. J Infect Dis 2002;185:389-92.
10. Tangkijvanich P, Hirsch P, Theamboonlers A, et al. Association of hepatitis viruses with hepatocellular carcinoma in Thailand. J Gastroenterol 1999;34:227-33.
11. Tangkijvanich P, Theamboonlers A, Sriponthong M, et al. SEN virus infection in patients with chronic liver disease and hepatocellular carcinoma in Thailand. J Gastroenterol 2003;38:142-8.
12. Breslow NE. Statistics in epidemiology: The case-control study. J Am Stat Assoc 1996;91:14-28.
13. Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent. Science 1996;271:505-8.
14. Simons JN, Pilot-Matias TJ, Leary TP, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci U S A 1995;92:3401-5.
15. Nishizawa T, Okamoto H, Konishi K, et al. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997;241:92-7.
16. Bowden S. New hepatitis viruses: Contenders and pretenders. J Gastroenterol Hepatol 2001;16:124-31.
17. Yoshida H, Kato N, Shiratori Y, et al. Weak association between SEN virus viremia and liver disease. J Clin Microbiol 2002;40:3140-5.
18. Wong SG, Primi D, Kojima H, et al. Insights into SEN virus prevalence, transmission, and treatment in community-based persons and patients with liver disease referred to a liver disease unit. Clin Infect Dis 2002;35:789-95.
19. Mikuni M, Moriyama M, Tanaka N, et al. SEN virus infection does not affect the progression of non-A to -E liver disease. J Med Virol 2002;67:624-9.
20. Naoumov NV. TT virus-highly prevalent, but still in search of a disease. J Hepatol 2000;33:157-9.
21. Chuang WL, Chang WY, Lu SN, et al. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area. A case-control study. Cancer 1992;69:2052-4.
22. Kaklamani E, Trichopoulos D, Tzonou A, et al. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma. JAMA 1991;265:1974-6.
23. Kew MC, Yu MC, Kedda MA, et al. The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks. Gastroenterology 1997;112:184-7.
24. Tsai JF, Jeng JE, Ho MS, et al. Independent and additive effect modification of hepatitis C and B viruses infection on the development of chronic hepatitis. J Hepatol 1996;24:271-6.